Загрузка...
Willingness to Take Buprenorphine/Naloxone Among People Who Use Opioids in Vancouver, Canada
OBJECTIVES: Opioid agonist therapy is the cornerstone of treatment of opioid use disorder. In Canada, buprenorphine/naloxone has recently been adopted as the first line agonist therapy given its comparable effectiveness to methadone and superior safety profile. This study examines factors associated...
Сохранить в:
| Опубликовано в: : | Drug Alcohol Depend |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894418/ https://ncbi.nlm.nih.gov/pubmed/31706251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2019.107672 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|